-
< Back to Bill Search
-
Senate Committee References (3)
-
Related Bills (5)
Bill Number Subject Filed By Last Action and Location Relationship Learn more about bill relationships S 1554 by Burgess
Public Records/Experimental Treatment Outcomes
Last Action: 3/13/2026 S Died in Health PolicyLinked S 1556 by Burgess
Experimental Treatment Access Trust Fund/Department of Health
Last Action: 3/13/2026 S Died in Health PolicyLinked H 1381 by Franklin
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 H Died in Health Professions & Programs SubcommitteeIdentical H 1383 by Franklin
Pub. Rec./Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 H Died in Health Professions & Programs SubcommitteeCompare H 1385 by Franklin
Trust Funds/Creation/Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 H Died in Health Professions & Programs SubcommitteeCompare -
Citations - Statute (1)
The page numbers, when listed, for citations are constantly under review. The journals or printed bills of the respective chambers should be consulted as the official documents of the Legislature.
The links for the page numbers are formatted to open the bill text PDF directly to the page containing the citation. However, if your browser is set to open PDFs in a new window, as is often the case with 64-bit browsers, the bill text will open to the first page.499.0295 Experimental treatments for terminal conditions. Page 3 (pdf) -
Bill History
S = Senate, H = House
1/9/2026 S • Filed
1/16/2026 S • Referred to Health Policy; Appropriations Committee on Health and Human Services; Appropriations
1/22/2026 S • Introduced
3/13/2026 S • Died in Health Policy
SB 1552: Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
GENERAL BILL by Burgess
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases; Citing this act as the “Promising Pathways Act"; authorizing licensed physicians to prescribe and eligible facilities to administer experimental treatments, if certain requirements are met; requiring the Department of Health to establish and maintain a patient registry for specified purposes; encouraging health insurers and health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizing licensed physicians and eligible facilities to receive reimbursement for the prescription or administration of experimental treatments if certain requirements are met; requiring manufacturers of experimental treatments to provide for a specified temporary price concession set by the department, etc.
Effective Date: Upon becoming a law
Last Action: 3/13/2026 Senate - Died in Health Policy
Current Bill Version Posted: 1/9/2026 08:26 AM